- Home
- SHPH
as 12-18-2024 1:42pm EST
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | GAITHERSBURG |
| Market Cap: | 2.7M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 77.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.29 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.62 - $4.94 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Shuttle Pharmaceuticals Holdings Inc. News
SHPH Breaking Stock News: Dive into SHPH Ticker-Specific Updates for Smart Investing
GlobeNewswire
22 days ago
Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
GlobeNewswire
a month ago
Shuttle Pharma Provides Third Quarter 2024 Corporate Update
GlobeNewswire
2 months ago
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
2 months ago
Shuttle Pharma Pays Off Senior Secured Convertible Note
GlobeNewswire
2 months ago
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
GlobeNewswire
2 months ago
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
GlobeNewswire
2 months ago
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024
MT Newswires
3 months ago
Shuttle Pharmaceuticals Launches Equity Offering
Compare SHPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SHPH Shuttle Pharmaceuticals Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.